Compare RCMT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCMT | LAB |
|---|---|---|
| Founded | 1971 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.8M | 270.6M |
| IPO Year | 1997 | 2008 |
| Metric | RCMT | LAB |
|---|---|---|
| Price | $37.51 | $0.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $45.00 | N/A |
| AVG Volume (30 Days) | 69.8K | ★ 865.8K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.38 | ★ 61.54 |
| EPS | ★ 1.20 | 0.26 |
| Revenue | ★ $186,737,000.00 | $101,937,000.00 |
| Revenue This Year | $11.47 | N/A |
| Revenue Next Year | $10.09 | N/A |
| P/E Ratio | $31.84 | ★ $2.53 |
| Revenue Growth | ★ 5.83 | N/A |
| 52 Week Low | $17.26 | $0.63 |
| 52 Week High | $43.68 | $1.72 |
| Indicator | RCMT | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 36.38 | 37.51 |
| Support Level | $27.02 | $0.63 |
| Resistance Level | $42.92 | $0.79 |
| Average True Range (ATR) | 1.40 | 0.05 |
| MACD | -0.57 | -0.01 |
| Stochastic Oscillator | 7.97 | 1.81 |
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions, including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, and Europe.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.